Russell Basser
Director/Board Member bij STARPHARMA HOLDINGS LIMITED
Profiel
Russell Basser is currently a Director at Medical Developments International Ltd., an Independent Non-Executive Director at Starpharma Holdings Ltd., and the Chief Medical Officer at CSL Ltd.
(United States).
Previously, he worked at CSL Behring LLC as the Senior VP-Global Clinical Research & Development from 2014 to 2022.
Basser received his undergraduate and doctorate degrees from the University of Melbourne.
Actieve functies van Russell Basser
| Bedrijven | Functie | Begin |
|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Director/Board Member | 20-02-2023 |
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Director/Board Member | 01-09-2023 |
| CSL Ltd. (United States) | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Russell Basser
| Bedrijven | Functie | Einde |
|---|---|---|
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Chief Tech/Sci/R&D Officer | 01-04-2022 |
Opleiding van Russell Basser
| University of Melbourne | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Health Technology |
| STARPHARMA HOLDINGS LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
| CSL Ltd. (United States) |
